These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25188517)

  • 1. PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.
    Ma JX; Yan BX; Zhang J; Jiang BH; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
    Cell Death Dis; 2014 Sep; 5(9):e1407. PubMed ID: 25188517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer.
    Yan BX; Ma JX; Zhang J; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
    Oncogene; 2014 Nov; 33(45):5288-94. PubMed ID: 24186202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
    Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
    J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
    Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin.
    Yan BX; Ma JX; Zhang J; Guo Y; Mueller MD; Remick SC; Yu JJ
    Cell Death Dis; 2014 Jan; 5(1):e995. PubMed ID: 24434518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostasin, a potential tumor marker in ovarian cancer--a pilot study.
    Costa FP; Batista EL; Zelmanowicz A; Svedman C; Devenz G; Alves S; Silva AS; Garicochea B
    Clinics (Sao Paulo); 2009; 64(7):641-4. PubMed ID: 19606239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
    Chen PX; Li QY; Yang Z
    Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.
    Anklesaria JH; Mhatre DR; Mahale SD
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):535-562. PubMed ID: 28930560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
    Helland Å; Anglesio MS; George J; Cowin PA; Johnstone CN; House CM; Sheppard KE; Etemadmoghadam D; Melnyk N; Rustgi AK; Phillips WA; Johnsen H; Holm R; Kristensen GB; Birrer MJ; ; Pearson RB; Børresen-Dale AL; Huntsman DG; deFazio A; Creighton CJ; Smyth GK; Bowtell DD
    PLoS One; 2011 Apr; 6(4):e18064. PubMed ID: 21533284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition mediated by PSP94 or CRISP-3 is prostate cancer cell line specific.
    Pathak BR; Breed AA; Nakhawa VH; Jagtap DD; Mahale SD
    Asian J Androl; 2010 Sep; 12(5):677-89. PubMed ID: 20676114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
    Busch B; Bley N; Müller S; Glaß M; Misiak D; Lederer M; Vetter M; Strauß HG; Thomssen C; Hüttelmaier S
    Nucleic Acids Res; 2016 May; 44(8):3845-64. PubMed ID: 26917013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.
    Van Eynde A; Litovkin K; Bollen M
    Asian J Androl; 2011 Mar; 13(2):205-6. PubMed ID: 21102472
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates.
    Xuan JW; Wu D; Guo Y; Garde S; Shum DT; Mbikay M; Zhong R; Chin JL
    DNA Cell Biol; 1997 May; 16(5):627-38. PubMed ID: 9174167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of prostate secretory protein PSP94 shows an edge-to-edge association of two monomers to form a homodimer.
    Kumar A; Jagtap DD; Mahale SD; Kumar M
    J Mol Biol; 2010 Apr; 397(4):947-56. PubMed ID: 20184897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate secretory protein 94 inhibits sterol binding and export by the mammalian CAP protein CRISP2 in a calcium-sensitive manner.
    El Atab O; Kocabey AE; Asojo OA; Schneiter R
    J Biol Chem; 2022 Mar; 298(3):101600. PubMed ID: 35063506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo Independent.
    Hikasa H; Sekido Y; Suzuki A
    Cell Rep; 2016 Mar; 14(12):2950-61. PubMed ID: 26997273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong expression association between matriptase and its substrate prostasin in breast cancer.
    Bergum C; Zoratti G; Boerner J; List K
    J Cell Physiol; 2012 Apr; 227(4):1604-9. PubMed ID: 21678412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostasin regulates iNOS and cyclin D1 expression by modulating protease-activated receptor-2 signaling in prostate epithelial cells.
    Chen LM; Hatfield ML; Fu YY; Chai KX
    Prostate; 2009 Dec; 69(16):1790-801. PubMed ID: 19670249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostasin Impairs Epithelial Growth Factor Receptor Activation to Suppress Dengue Virus Propagation.
    Lin CK; Tseng CK; Wu YH; Lin CY; Huang CH; Wang WH; Liaw CC; Chen YH; Lee JC
    J Infect Dis; 2019 Apr; 219(9):1377-1388. PubMed ID: 30476206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.